Terry-Ann Burrell
CIK 1786484 · Chief Financial Officer · last filed 2024-07-03
Terry-Ann Burrell is a Chief Financial Officer who has filed 37 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for RXRX, was dated Oct 17, 2024. Across all open-market trades the lifetime net is −$17.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.7M across reported positions. 20 SEC filings were submitted jointly with Beam Therapeutics Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.71M
2
37
-$17.10M
Filer Profile
26 LANDSDOWNE STREET
CAMBRIDGE, MA 02139
Holdings By Company
Recent Filings
37 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-10-17 | RXRX | Notice (144) | −404,688 | -$2.69M | EDGAR |
| 2024-10-07 | BEAM | Notice (144) | −185,565 | -$4.27M | EDGAR |
| 2024-07-03 | RXRX | Grant (A) | +1,843 | $0 | EDGAR |
| 2024-06-05 | RXRX | Grant (A) | +13,097 | $0 | EDGAR |
| 2024-04-29 | BEAM | Grant (A) | +12,500 | $0 | EDGAR |
| 2024-04-04 | BEAM | Notice (144) | −5,446 | -$174.9K | EDGAR |
| 2024-04-03 | RXRX | Grant (A) | +1,467 | $0 | EDGAR |
| 2024-04-03 | BEAM | Sell (S) | −5,446 | -$174.9K | EDGAR |
| 2024-04-02 | BEAM | Grant (A) | +27,500 | $0 | EDGAR |
| 2024-02-02 | BEAM | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.